Potent modulators of the immune system, befittingly referred to as 'su
perantigens', have been implicated as causative agents in disorders ra
nging from food poisoning to lethal toxic shock syndromes. Association
of a superantigen component with development of the murine acquired i
mmunodeficiency syndrome (MAIDS) strongly suggests the possibility of
similar involvement in the aetiology of HIV infection. Verification of
a superantigen facet to the pathogenesis of AIDS in humans is now the
objective of research efforts focusing on the probable occurrence of
dysfunction or depletion among T cells bearing specific T cell recepto
r Vp chain families. The present discussion reviews progress in this g
rowing field of investigation, concentrating on the implications of su
perantigen-induced immune destruction for the development of potential
therapeutic protocols. The adaptability of intervention strategies cu
rrently being employed in other disease states characterised by select
ive T cell alteration is evaluated and placed in this perspective.